Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase

Journal of Molecular Biology

Volumn 343, Issue 5, 2004, Pages 1255-1268

  Choi, Hyun Jung ^a   Smithgall, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Hck; HIV; Nef; SH3 domain; Src kinase family

Indexed keywords

HEMATOPOIETIC CELL KINASE; NEF PROTEIN; VIRUS PROTEIN;

ALLELE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; MACROPHAGE; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; SUBSTITUTION REACTION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; RODENTIA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 6344276677     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.09.015     Document Type: Article

References (47)

1. S.T. Arold, and A.S. Bauer Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein Trends Biochem. Sci. 26 2001 356 363
2. M. Geyer, O.T. Fackler, and B.M. Peterlin Structure-function relationships in HIV-1 Nef EMBO Rep. 2 2001 580 585
3. R.G. Herna, and K. Saksela Interactions of HIV-1 NEF with cellular signal transducing proteins Front Biosci. 5 2000 D268 D283
4. H.W. Kestler III, D.J. Ringler, K. Mori, D.L. Panicali, P.K. Sehgal, M.D. Daniel, and R.C. Desrosiers Importance of the nef gene for maintenance of high virus loads and for development of AIDS Cell 65 1991 651 662
5. N.J. Deacon, A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, and D.J. Hooker Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients Science 270 1995 988 991
6. R. Mariani, F. Kirchhoff, T.C. Greenough, J.L. Sullivan, R.C. Desrosiers, and J. Skowronski High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection J. Virol. 70 1996 7752 7764
7. F. Kirchhoff, T.C. Greenough, D.B. Brettler, J.L. Sullivan, and R.C. Desrosiers Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection N. Engl. J. Med. 332 1995 228 232
8. Z. Hanna, D.G. Kay, N. Rebai, A. Guimond, S. Jothy, and P. Jolicoeur Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice Cell 95 1998 163 175
9. G.H. Renkema, and K. Saksela Interactions of HIV-1 NEF with cellular signal transducing proteins Front Biosci. 5 2000 D268 D283
10. C.H. Lee, K. Saksela, U.A. Mirza, B.T. Chait, and J. Kuriyan Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain Cell 85 1996 931 942
11. A. Manninen, M. Hiipakka, M. Vihinen, W. Lu, B.J. Mayer, and K. Saksela SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase Virology 250 1998 273 282
12. K. Saksela, G. Cheng, and D. Baltimore Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+viruses but not for down-regulation of CD4 EMBO J. 14 1995 484 491
13. Z. Hanna, X. Weng, D.G. Kay, J. Poudrier, C. Lowell, and P. Jolicoeur The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck J. Virol. 75 2001 9378 9392
14. A. Brown, S. Moghaddam, T. Kawano, and C. Cheng-Mayer Multiple human immunodeficiency virus type 1 Nef functions contribute to efficient replication in primary human macrophages J. Gen. Virol. 85 2004 1463 1469
15. C.H. Lee, B. Leung, M.A. Lemmon, J. Zheng, D. Cowburn, J. Kuriyan, and K. Saksela A single amino-acid in the Sh3 domain of Hck determines its high-affinity and specificity in binding to Hiv-1 Nef protein EMBO J. 14 1995 5006 5015
16. I. Komuro, Y. Yokota, S. Yasuda, A. Iwamoto, and K.S. Kagawa CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection J. Expt. Med. 198 2003 443 453
17. S.D. Briggs, M. Sharkey, M. Stevenson, and T.E. Smithgall SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1 J. Biol. Chem. 272 1997 17899 17902
18. T. Schindler, F. Sicheri, A. Pico, A. Gazit, A. Levitzki, and J. Kuriyan Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor Mol. Cell 3 1999 639 648
19. F. Sicheri, I. Moarefi, and J. Kuriyan Crystal structure of the Src family tyrosine kinase Hck Nature 385 1997 602 609
20. W. Xu, S.C. Harrison, and M.J. Eck Three-dimensional structure of the tyrosine kinase c-Src Nature 385 1997 595 602
21. W. Xu, A. Doshi, M. Lei, M.J. Eck, and S.C. Harrison Crystal structures of c-Src reveal features of its autoinhibitory mechanism Mol. Cell 3 1999 629 638
22. S.D. Briggs, and T.E. Smithgall SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts J. Biol. Chem. 274 1999 26579 26583
23. I. Moarefi, M. LaFevre-Bernt, F. Sicheri, M. Huse, C.H. Lee, J. Kuriyan, and W.T. Miller Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement Nature 385 1997 650 653
24. S.J. Schreiner, A.P. Schiavone, and T.E. Smithgall Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain J. Biol. Chem. 277 2002 45680 45687
25. W.T. Miller Determinants of substrate recognition in nonreceptor tyrosine kinases Accts Chem. Res. 36 2003 393 400
26. M. Geyer, and B.M. Peterlin Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef FEBS Letters 496 2001 91 95
27. S. Arold, R. O'Brien, P. Franken, M.P. Strub, F. Hoh, C. Dumas, and J.E. Ladbury RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef Biochemistry 37 1998 14683 14691
28. S.D. Briggs, B. Scholtz, J.M. Jacque, S. Swingler, M. Stevenson, and T.E. Smithgall HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway J. Biol. Chem. 276 2001 25605 25611
29. S.D. Briggs, E.C. Lerner, and T.E. Smithgall Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo Biochemistry 39 2000 489 495
30. D.C. Shugars, M.S. Smith, D.H. Glueck, P.V. Nantermet, F. Seillier-Moiseiwitsch, and R. Swanstrom Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo J. Virol. 67 1993 4639 4650
31. E.C. Lerner, and T.E. Smithgall SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo Nature Struct. Biol. 9 2002 365 369
32. F. Kirchhoff, P.J. Easterbrook, N. Douglas, M. Troop, T.C. Greenough, and J. Weber Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease J. Virol. 73 1999 5497 5508
33. M. Tobiume, M. Takahoko, T. Yamada, M. Tatsumi, A. Iwamoto, and M. Matsuda Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors J. Virol. 76 2002 5959 5965
34. M. Catucci, G. Venturi, L. Romano, P.E. Valensin, and M. Zazzi Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy J. Med. Virol. 60 2000 294 299
35. A. Brambilla, L. Turchetto, A. Gatti, C. Bovolenta, F. Veglia, and E. Santagostino Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection Virology 259 1999 349 368
36. S. Grzesiek, A. Bax, G.M. Clore, A.M. Gronenborn, J.S. Hu, and J. Kaufman The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase Nature Struct. Biol. 3 1996 340 345
37. L. Wan, S.S. Molloy, L. Thomas, G. Liu, Y. Xiang, S.L. Rybak, and G. Thomas PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization Cell 94 1998 205 216
38. V. Piguet, L. Wan, C. Borel, A. Mangasarian, N. Demaurex, G. Thomas, and D. Trono HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes Nature Cell Biol. 2 2000 163 167
39. A.D. Blagoveshchenskaya, L. Thomas, S.F. Feliciangeli, C.H. Hung, and G. Thomas HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway Cell 111 2002 853 866
40. A.L. Greenway, H. Dutartre, K. Allen, D.A. McPhee, D. Olive, and Y. Collette Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation J. Virol. 73 1999 6152 6158
41. Y. Collette, S. Arold, C. Picard, K. Janvier, S. Benichou, and R. Benarous HIV-2 and SIV Nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution J. Biol. Chem. 275 2000 4171 4176
42. T. Karn, B. Hock, U. Holtrich, M. Adamski, K. Strebhardt, and H. Rubsamen-Waigmann Nef proteins of distinct HIV-1 or -2 isolates differ in their binding properties for HCK: isolation of a novel Nef binding factor with characteristics of an adaptor protein Virology 246 1998 45 52
43. K. Peden, M. Emerman, and L. Montagnier Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI Virology 185 1991 661 672
44. M. Alizon, S. Wain-Hobson, L. Montagnier, and P. Sonigo Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients Cell 46 1986 63 74
45. J.A. Rogers, H.Y. Cheng, and T.E. Smithgall Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase Cell Growth Differ. 11 2000 581 592
46. J.A. Rogers, R.D. Read, J. Li, K.L. Peters, and T.E. Smithgall Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues J. Biol. Chem. 271 1996 17519 17525
47. H.Y. Cheng, A.P. Schiavone, and T.E. Smithgall A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells Mol. Cell Biol. 21 2001 6170 6180